Champignon Appoints Dr Bill Wilkerson To Board Of Directors

Champignon Brands (CSE: SHRM) this morning continued its ongoing process of strengthening its board of directors with accomplished executives and thought leaders in the medical space with the appointment of Dr Bill Wilkerson, LL.D (Hon).

Dr Wilkerson is a highly accomplished executive in the areas of business, government, broadcasting, arts, and corporate crisis management. He has been an 8-time award-winner in workplace mental health, following an international initiative conducted from 1998 to 2012 to enforce the significance of mental health among major employers.

In terms of previous employment, Dr Wilkerson was previously President of Liberty Health, one of Canada’s largest benefits providers, and held executive roles at RBC, CBC, and the Toronto Symphony Orchestra. As an adviser for mental health, his career has been just as impressive, having worked with the NHL, the CFL, the Hockey Hall of Fame, Toronto Blue Jays, TSN, CTV, and more.

"I am pleased to join the board of directors of Champignon to help deploy, at long last, treatments of depression that work, work fast, restore health, fuel hope, animate workplace productivity, and save lives. The mission of this company is fundamental and enduring; to meet a pressing public need. This is what my twenty-two years of advocacy for mental health in the workplace has been all about. This directorship also permits me to support and help facilitate the vision of the extraordinarily skilled and dedicated physician-scientist Dr. Roger McIntyre, a world leader in a field that cries out for his kind of resolve, courage, compassion, and knowledge. I am humbled by, and grateful for, the opportunity to serve." 
Dr Bill Wilkerson

In conjunction with the appointment of Dr Bill Wilkerson, Joe Perino has resigned from Champignon’s board of directors.

Champignon Brands last traded at $1.63 on the CSE.


FULL DISCLOSURE: Champignon Brands is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Champignon Brands on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

New Found Gold: The Strategic Maritime Resources Purchase

Amex Exploration: Revised Perron PEA Has INSANE Economics

Aris Mining: The Multi Billion Dollar Soto Norte PFS

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Champignon Brands Latest Shroom Stock To IPO

Champignon Brands (CSE: SHRM) completed its initial public offering (IPO) late Friday night, with the...

Monday, March 2, 2020, 10:40:37 AM

Champignon Brands To Change Name To Braxia Scientific

Champignon Brands (CSE: SHRM) is evidently looking to turn a new leaf, with the company...

Monday, May 3, 2021, 07:16:21 AM

Champignon Brands Announces Contract Research Partner For Ketamine, Psilocybin IP Portfolio

Champignon Brands (CSE: SHRM) announced this morning that it is advancing its drug discovery program...

Monday, June 8, 2020, 10:03:37 AM

Champignon Brands Files Required Disclosures With Exchange, Resumption Of Trading In Hands Of BCSC

Champignon Brands (CSE: SHRM) has completed the regulatory filings required as per the review previously...

Friday, July 24, 2020, 05:33:15 PM

Braxia Scientific Launches Multiple-Dose Psilocybin Clinical Trial for Treatment-Resistant Depression

Braxia Scientific Corp. (CSE: BRAX), formerly Champignon Brands, announced today that its clinical research and...

Friday, August 27, 2021, 08:20:00 AM